| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/13/2004 | WO2004039941A2 METHODS OF SCREENING FOR TRPM4b MODULATORS |
| 05/13/2004 | WO2004039837A2 Crh responsive genes in cns |
| 05/13/2004 | WO2004039831A2 Peptide nucleic acid probes for analysis of enterococcus faecium |
| 05/13/2004 | WO2004039487A1 Multicomponent protein microarrays |
| 05/13/2004 | WO2004039407A1 Apoptosis inducer |
| 05/13/2004 | WO2004039354A1 Solvent for chromogenic substrate solution |
| 05/13/2004 | WO2004039312A2 Optineurin and glaucoma |
| 05/13/2004 | WO2004039311A2 Human vps4a and vps4b functions in viral budding |
| 05/13/2004 | WO2004039309A2 Dc-sign isoforms, related compositions and methods for their use in disease therapy |
| 05/13/2004 | WO2004039307A2 Methods and compositions for diagnosing and treating companion animal cancer |
| 05/13/2004 | WO2004033720A3 Analytical chip for detection of 16s-rrna from clinically relevant bacteria and analytical method based thereon |
| 05/13/2004 | WO2004027418A3 The use of molecular markers for the preclinical and clinical profiling of inhibitors of enzymes having histone deacetylase activity |
| 05/13/2004 | WO2004020602A3 Terminal phosphate blocked nucleoside polyphosphates |
| 05/13/2004 | WO2004019036A3 Method for identifying substances |
| 05/13/2004 | WO2004013357A3 Nucleotide sequences specific to francisella tularensis and methods for the detection of francisella tularensis |
| 05/13/2004 | WO2004013274A3 Ghrelin binding nucleic acids |
| 05/13/2004 | WO2004009840A9 Capture and detection of microbes by membrane methods |
| 05/13/2004 | WO2004005542A3 Method for identifying infection-specific regulated genes of the skin |
| 05/13/2004 | WO2003104420A3 Electrochemical detection of single nucleotide polymorphisms (snps) |
| 05/13/2004 | WO2003104406A3 Improvements for combinatorial oligonucleotide pcr |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003098187A3 Assays and kits for detecting the presence of nitriles and/or cyanide |
| 05/13/2004 | WO2003092467A3 Compositions and methods relating to abca1-mediated cholesterol efflux |
| 05/13/2004 | WO2003083757A3 Methods and computer program products for the quality control of nucleic acid assays |
| 05/13/2004 | WO2003079747A3 An isolated polynucleotide associated with type ii diabetes mellitus and methods of use thereof |
| 05/13/2004 | WO2003066891A3 Genetic markers for the diagnosis of the expression of inverted nipples in pets, breeding animals and domestic cattle |
| 05/13/2004 | WO2003057014A3 Biomarkers for detecting ovarian cancer |
| 05/13/2004 | WO2003053921A9 Mutant proteinase inhibitors and uses thereof |
| 05/13/2004 | WO2003052050A3 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |
| 05/13/2004 | WO2003033657A3 Antisense antiviral agent and method for treating ssrna viral infection |
| 05/13/2004 | WO2003018595A3 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/13/2004 | WO2003014381A9 System for detecting protease |
| 05/13/2004 | WO2003006950B1 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 05/13/2004 | WO2003006652A3 Inhibition of specific histone deacetylase isoforms |
| 05/13/2004 | WO2003003014A9 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 05/13/2004 | WO2002064735A3 Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
| 05/13/2004 | WO2002062836A9 Detection of antibacterial activity in excretory secretory product of adult trichuris suis |
| 05/13/2004 | WO2002061041A9 Solubility reporter gene constructs |
| 05/13/2004 | WO2002000232A9 Methods and compositions for developing spore display systems for medicinal and industrial applications |
| 05/13/2004 | US20040092738 Hydrolysis of 3,7-dialkanoyloxyphenoxazine derivative; measuring fluorescence |
| 05/13/2004 | US20040092715 Intracellular signaling molecules |
| 05/13/2004 | US20040092714 Comprises osteoclast associated receptors (OSCAR) for the identifying modulators for treatment of bone disorders |
| 05/13/2004 | US20040092711 Hybrid expression of neisserial proteins |
| 05/13/2004 | US20040092486 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 05/13/2004 | US20040092474 Controlling cell proliferation; contacting cell with reporter molecules; measuring, calibrating activation |
| 05/13/2004 | US20040092461 Modulation of phosphodiesterase 1B expression |
| 05/13/2004 | US20040092446 HA-1 epitopes and uses thereof |
| 05/13/2004 | US20040092441 Tyrosine kinase modulators |
| 05/13/2004 | US20040092026 Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents |
| 05/13/2004 | US20040092007 Allelic growth differentiation factor-9b (GDF-9B) for treatment annd prevention of sex disorders; in vitro fertilization; artificial insemination; veterinary medicine |
| 05/13/2004 | US20040092005 Using acid/alkali hydrolysis to recycle matrix comprising oligonucleotides immobilized via acid-amido bonding; reusable solid support for nucleotide sequences analysis |
| 05/13/2004 | US20040092004 Substrates, electrodes, sol-gel matrix containing enzyme; indicator of biological warfare |
| 05/13/2004 | US20040091993 Comprises peptides associated with rho/rac-interacting citron kinase for identifying modulators for treatment, diagnosis and prevention of cell proliferative disorders |
| 05/13/2004 | US20040091992 Comprises nucleotide sequences coding serine/threonine kinase for use in diagnosis, prevention and treatment or arthritic and cell proliferative disorders |
| 05/13/2004 | US20040091988 Methods and compositions employing a novel stearoyl-coa desaturase-hscd5 |
| 05/13/2004 | US20040091964 Modified proteins, isolated novel peptides,and uses thereof |
| 05/13/2004 | US20040091959 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; diagnosis cancer |
| 05/13/2004 | US20040091953 Identifying modulator of silent information regulator 2 (Sir2) protein for use in transcriptional silencing and DNA damage repair; diagnosis, prevention and treatment of cancer |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/13/2004 | US20040091949 Method of screening drug acting on cell wall |
| 05/13/2004 | US20040091948 Identifying checkpoint kinase-1 modulators which decrease drug resistance in cancer cells; antitumor agents |
| 05/13/2004 | US20040091947 Screening strategy for anticancer drugs |
| 05/13/2004 | US20040091940 Latex particles conjugated two distinct monoclonal antibodies for diagnosis of pancreatitis and pancreatic cancer |
| 05/13/2004 | US20040091939 Device and method for detection of multiple analytes |
| 05/13/2004 | US20040091937 Use of fluorine NMR for high throughput screening |
| 05/13/2004 | US20040091935 Comprises nucleotide sequences coding mycoplasmal protein associated with autoimmune and skin disorders for treating and preventing scleroderma |
| 05/13/2004 | US20040091933 Methods for genetic interpretation and prediction of phenotype |
| 05/13/2004 | US20040091932 Fermenting and recovering enzymatic products from transgenic fungi coding cellulases, galactosidases, glucanases, glucosidases and xylanases for use in animal feeds, food processing, detergents, baking and brewing |
| 05/13/2004 | US20040091931 Comprises fusion protein for identifying ligands and/or treatment which modulate transmembrane binding; diagnosis and treatment of asthma, chronic obstructive pulmonary disease, cystic fibrosis, sinusitis, and nervous system disorders |
| 05/13/2004 | US20040091930 Products and methods for analyzing nucleic acids including identification of substitutes, insertions and deletions |
| 05/13/2004 | US20040091929 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 |
| 05/13/2004 | US20040091927 Method for the determination of data for the preparation of the diagnosis of phakomatosis |
| 05/13/2004 | US20040091925 Nucleic acid archiving |
| 05/13/2004 | US20040091924 Method for detecting base mutation |
| 05/13/2004 | US20040091923 Linked linear amplification of nucleic acids |
| 05/13/2004 | US20040091921 Method for gene expression analysis and kit for gene expression analysis |
| 05/13/2004 | US20040091916 Diagnosis of mutants; determination, calibration of disease; using computers; matching patterns |
| 05/13/2004 | US20040091915 Methods for predicting survival rate in patients having multiple sclerosis |
| 05/13/2004 | US20040091914 Gene assay method for predicting glaucoma onset risk |
| 05/13/2004 | US20040091913 Composition and method for imaging cells |
| 05/13/2004 | US20040091912 Diagnostic method |
| 05/13/2004 | US20040091910 Isolation of RNA, DNA and proteins from formalin-fixed paraffin-embedded tissue specimens |
| 05/13/2004 | US20040091909 Identifying polymorphism in a gene by incubating a reaction comprising nucleic acid, polymerase, extension primers and labeled nucleotide triphosphates; allows tailoring of drug therapy based on the individuals metabolism |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091906 Correlating biochemical component(DNA) of cell to nuclear volume using mathematical techniques; use in characterizing based on desired phenotype or differentiating among benign, malignant and metastatic states to diagnose cancer |
| 05/13/2004 | US20040091905 Method for detecting mutated polynucleotides within a large population of wild-type polynucleotides |
| 05/13/2004 | US20040091904 Methods for identifying compounds that bind to a target |
| 05/13/2004 | US20040091903 Immobilised by covalent bonding to a solid planar surface and separated to allow each to be individually resolved by optical microscopy |
| 05/13/2004 | US20040091897 Disease associated polymorphism in the ctla-4 locus |
| 05/13/2004 | US20040091895 Human sprouty-4 polypeptide |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/13/2004 | US20040091893 Measuring and comparing gene expression in bacterium-colonized and germ-free stomachs; DNA microarray analysis and/or polymerase chain reaction; evaluation of biochemical pathway of angiogenin-4 or colipase |
| 05/13/2004 | US20040091892 Restriction endonucleases, method of synthesis and use thereof |
| 05/13/2004 | US20040091890 Life sciences business systems and methods |
| 05/13/2004 | US20040091889 Obtaining tissue or sample DNA or RNA from a potential tumor cell; Amplification by polymerase chain reaction; Southern hybridization or RNase A mismatch cleavage; useful in diagnosis and prognosis of cancer |
| 05/13/2004 | US20040091888 DNA fragment which consists of a nucleotide sequence contained in a cysteine-rich protein, receptor kinase or glycoprotein gene; determining haplotypes by immobilizing probes onto support and hybridizing |
| 05/13/2004 | US20040091885 Use of consensus sequences for targeted homologous gene isolation and recombination in gene families |